These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 267281)

  • 1. Portal hypertension in a patient with chronic myeloid leukaemia.
    Foadi MD; Shaw S; Paradinas FJ
    Postgrad Med J; 1977 May; 53(619):267-9. PubMed ID: 267281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine.
    Shepherd PC; Fooks J; Gray R; Allan NC
    Br J Haematol; 1991 Oct; 79(2):185-92. PubMed ID: 1958475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia.
    Key NS; Kelly PM; Emerson PM; Chapman RW; Allan NC; McGee JO
    Lancet; 1987 Nov; 2(8567):1050-2. PubMed ID: 2889964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukaemia and a myasthenic syndrome.
    Wohl MA; Wood JK
    Acta Haematol; 1979; 62(4):214-8. PubMed ID: 119414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic granulocytic leukaemia. Comparison of uracil mustard and busulphan.
    Herrmann RP; Dougan L; Holt JA; Jackson JM; Matthews ML; Nelson AJ; Stenhouse NS; Woodliff HJ
    Med J Aust; 1972 Apr; 1(16):789-91. PubMed ID: 4503393
    [No Abstract]   [Full Text] [Related]  

  • 6. Busulphan lung in childhood.
    Oakhill A; Green ID; Knowlson GT; Cameron AH; Shah KJ; Hill FG; Mann JR
    J Clin Pathol; 1981 May; 34(5):495-500. PubMed ID: 6941971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission induction in chronic granulocytic leukaemia using intermittent high-dose busulphan.
    Douglas ID; Wiltshaw E
    Br J Haematol; 1978 Sep; 40(1):59-64. PubMed ID: 280361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestatic jaundice following treatment of chronic granulocytic leukemia with busulphan.
    Underwood JC; Shahani RT; Blackburn EK
    J Clin Pathol; 1970 Dec; 23(9):827. PubMed ID: 5278972
    [No Abstract]   [Full Text] [Related]  

  • 9. Jaundice after treatment of leukemia with busulphan.
    Underwood JC; Shahani RT; Blackburn EK
    Br Med J; 1971 Mar; 1(5748):556-7. PubMed ID: 5280623
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
    Finney R; McDonald GA; Baikie AG; Douglas AS
    Br J Haematol; 1972 Sep; 23(3):283-8. PubMed ID: 4507535
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 12. [Varying course of pancytopenia after busulfan treatment of chronic myelocytic leukemia (CML)].
    Krug K; Stenzel L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):181-7. PubMed ID: 79522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnosis of atypical chronic myeloid leukaemia].
    Klein UE; Schwarze EW; Schwalbe P; Tolksdorf ME
    Dtsch Med Wochenschr; 1976 Jun; 101(24):915-20. PubMed ID: 1064523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal hypertension in chronic leukaemia.
    Datta DV; Grover SL; Saini VK; Datta BN; Aikat BK; Chhuttani PN
    Br J Haematol; 1975 Nov; 31(3):279-85. PubMed ID: 1059478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
    Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M
    Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of the duration of the chronic phase in chronic granulocytic leukaemia to the need for treatment during the first year after diagnosis.
    Wareham NJ; Johnson SA; Goldman JM
    Cancer Chemother Pharmacol; 1982; 8(2):205-10. PubMed ID: 6955071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic portal hypertension associated with cytotoxic drugs.
    Shepherd P; Harrison DJ
    J Clin Pathol; 1990 Mar; 43(3):206-10. PubMed ID: 2332518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged survival in chronic granulocytic leukaemia after busulphan induced hypoplasia and karyotype conversion.
    Bennett M; Lewis D; Walker H
    Br J Haematol; 1985 Apr; 59(4):738-40. PubMed ID: 3857075
    [No Abstract]   [Full Text] [Related]  

  • 19. Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.
    HAYHOE FG; KOK D
    Br Med J; 1957 Dec; 2(5059):1468-71. PubMed ID: 13489262
    [No Abstract]   [Full Text] [Related]  

  • 20. Busulphan haemorrhagic cystitis.
    Millard RJ
    Br J Urol; 1978 May; 50(3):210. PubMed ID: 288495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.